CardioFocus, Inc. — Form D/A

CardioFocus, Inc. of MARLBOROUGH, MA, a company, filed a Form D amendment with the SEC on 2018-04-18. The offering totals $21.0M, of which $13.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (55)

Showing 25 of 55 people.

NameRoleLocation
GREG R MADDENDirectorMARLBOROUGH, MA
PATRICK R WETHINGTONDirectorMARLBOROUGH, MA
BURKE R BARRETTExecutive OfficerMARLBOROUGH, MA
WARREN R CLARK, IIIExecutive OfficerMARLBOROUGH, MA
Paul C LaVioletteExecutive OfficerMarlborough, MA
Charles LarsenDirectorSuwanee, GA
Paul LaVioletteDirectorSeattle, WA
Paul LaVioletteExecutive OfficerSeattle, WA
Christopher A KroegerDirectorRedwood City, CA
James GarveyDirectorChicago, IL
David KhoDirectorRedmond, WA
Stephan OgilvieExecutive OfficerMarlborough, MA
Bruce RobertsonDirectorSouth San Francisco, CA
Scott FletcherExecutive OfficerMarlborough, MA
Gwen WatanabeDirectorMarlborough, MA
Patrick WethingtonDirectorMARLBOROUGH, MA
Omar AmiranaDirectorMARLBOROUGH, MA
Burke BarrettDirectorMARLBOROUGH, MA
Burke BarrettExecutive OfficerMARLBOROUGH, MA
OMAR C AMIRANADirectorMARLBOROUGH, MA
OMARI C BOUKNIGHTExecutive OfficerMARLBOROUGH, MA
GREG C MADDENDirectorMARLBOROUGH, MA
BURKE C BARRETTExecutive OfficerMARLBOROUGH, MA
PATRICK C WETHINGTONDirectorMARLBOROUGH, MA
James W GarveyDirectorChicago, IL

Other filings by this issuer (13)

FiledFormOfferingSold
2023-02-24D$31.8M$27.2M
2022-04-12D$50.0M$4.0M
2020-07-20D$15.0M$12.0M
2019-05-20D$12.0M$8.0M
2018-04-18D$21.0M$13.0M
2017-03-01D$32.1M$20.2M
2016-05-18D$12.0M$8.0M
2015-01-06D$33.2M$31.7M
2014-11-13D$2.3M$2.3M
2014-05-09D$5.0M$2.4M
2011-02-24D$15.6M$13.6M
2010-04-20D$5.0M$5.0M
2009-06-25D$9.2M$5.9M

More